September 27 – October 1 2019, Barcelona. Dr Razis and Dr Rigakos attended the 2019 European Society for Medical Oncology (ESMO) Congress. Dr Razis is a co-author of two Hellenic Cooperative Oncology Group (HeCOG) posters titled “Clinical outcome and toxicity data in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy in a real-world clinical setting” and “The clinical impact of adjuvant dose-dense sequential chemotherapy (dds-CT) in patients with high-risk operable breast cancer (BC); pooled analysis of 6 clinical trials”.
Style Sampler
Layout Style
Patterns for Boxed Mode
Backgrounds for Boxed Mode
Leave a Reply